Nonimmunologic graft failure after Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) for presumed amantadine-induced corneal edema.
BACKGROUND
With one exception, a case report of amantadine-induced corneal toxicity has described reversible corneal edema.


OBJECTIVE
To report a patient with unrecognized amantadine-induced corneal edema.


METHODS
Patient with schizophrenia and tardive dyskinesia developed bilateral corneal edema while receiving chronic amantadine hydrochloride. Both eyes underwent successful phakic Descemet's stripping automated endothelial keratoplasty, and histopathologic examination of the excised host tissue was performed.


RESULTS
Despite initial clearing of the donor lenticules, both eyes later experienced nonimmunologic graft failure, probably related to continued amantadine corneal toxicity. After discontinuation of the amantadine, one graft demonstrated partial clearing. Histopathology demonstrated endothelial cell loss. Specular microscopy demonstrated pleomorphism and disruption of the orderly hexagonal array.


CONCLUSIONS
Chronic amantadine hydrochloride therapy may be responsible for irreversible corneal edema and may lead to graft failure in unrecognized cases.
Koenig
Steven B
SB
Eye Institute, Froedtert and Medical College of Wisconsin, Milwaukee, 53226, USA. skoenig@mcw.edu
McDermott
Mark L
ML
Simons
Kenneth B
KB
D000328:Adult; D000547:Amantadine / Q000008:administration & dosage / Q000009:adverse effects*; D001331:Automation; D015715:Corneal Edema / Q000139:chemically induced* / Q000601:surgery*; D016039:Corneal Transplantation / Q000379:methods*; D003886:Descemet Membrane / Q000601:surgery*; D004334:Drug Administration Schedule; D004728:Endothelium, Corneal / Q000637:transplantation*; D005260:Female; D006801:Humans; D012086:Reoperation; D017211:Treatment Failure
D000547:Amantadine